-
1
-
-
17944368846
-
Recombinant activated factor VII (rFVIIa): Characterization, manufacturing and clinical development
-
Jurlander B, Thim L, Klausen NK et al. Recombinant activated factor VII (rFVIIa): Characterization, manufacturing and clinical development. Semin Thromb Hemost 2001; 27: 373-383.
-
(2001)
Semin Thromb Hemost
, vol.27
, pp. 373-383
-
-
Jurlander, B.1
Thim, L.2
Klausen, N.K.3
-
2
-
-
0036363842
-
Potential role for rFVIIa in transfusion medicine
-
Hedner U, Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion 2002; 42: 114-124.
-
(2002)
Transfusion
, vol.42
, pp. 114-124
-
-
Hedner, U.1
Erhardtsen, E.2
-
3
-
-
3242709784
-
Recombinant activated factor VIII for non-hemophiliac bleeding patients
-
Uhlmann EJ, Eby CS. Recombinant activated factor VIII for non-hemophiliac bleeding patients. Curr Opin Hematol 2004; 11: 198-204.
-
(2004)
Curr Opin Hematol
, vol.11
, pp. 198-204
-
-
Uhlmann, E.J.1
Eby, C.S.2
-
4
-
-
20444452505
-
Recombinant factor VIIa. An update on its clinical use
-
Franchini M, Zaffanello M, Veneri D. Recombinant factor VIIa. An update on its clinical use. Thromb Haemost 2005; 93: 1027-1035
-
(2005)
Thromb Haemost
, vol.93
, pp. 1027-1035
-
-
Franchini, M.1
Zaffanello, M.2
Veneri, D.3
-
5
-
-
0033784063
-
New products for managing inhibitors to coagulation factors: A focus on recombinant factor VIIa concentrate
-
Kessler CM. New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate. Curr Opin Hematol 2000; 7: 408-413.
-
(2000)
Curr Opin Hematol
, vol.7
, pp. 408-413
-
-
Kessler, C.M.1
-
6
-
-
6344239341
-
Off-license' use of recombinant activated factor VII
-
Ghorashian S, Hunt BJ. 'Off-license' use of recombinant activated factor VII. Blood Rev 2004; 18: 245-259.
-
(2004)
Blood Rev
, vol.18
, pp. 245-259
-
-
Ghorashian, S.1
Hunt, B.J.2
-
7
-
-
6344291879
-
The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics
-
Mathew P. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. Thromb Haemost 2004; 92: 738-746.
-
(2004)
Thromb Haemost
, vol.92
, pp. 738-746
-
-
Mathew, P.1
-
8
-
-
0346921344
-
Mechanism of action of recombinant factor VIIa
-
Lisman T, De Groot PG. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003; 1: 1138-1139.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 1138-1139
-
-
Lisman, T.1
De Groot, P.G.2
-
9
-
-
19044370248
-
Treatment of bleeding in patients with platelet disorders: Is there a place for recombinant factor VIIa?
-
Laurian Y. Treatment of bleeding in patients with platelet disorders: Is there a place for recombinant factor VIIa? Pathophysiol Haemost Thromb 2002; 32: 37-40
-
(2002)
Pathophysiol Haemost Thromb
, vol.32
, pp. 37-40
-
-
Laurian, Y.1
-
10
-
-
0032698580
-
Inherited abnormalities of platelets
-
Nurden AT. Inherited abnormalities of platelets. Thromb Haemost 1999; 82: 468-480.
-
(1999)
Thromb Haemost
, vol.82
, pp. 468-480
-
-
Nurden, A.T.1
-
11
-
-
0029961868
-
A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa
-
Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost 1996; 75: 981-982.
-
(1996)
Thromb Haemost
, vol.75
, pp. 981-982
-
-
Tengborn, L.1
Petruson, B.2
-
12
-
-
0032703537
-
Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa
-
Chuansumrit A, Sangkapreecha C, Hathirat P. Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa. Thromb Haemost 1999; 82: 1778.
-
(1999)
Thromb Haemost
, vol.82
, pp. 1778
-
-
Chuansumrit, A.1
Sangkapreecha, C.2
Hathirat, P.3
-
13
-
-
0033485862
-
Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia
-
Poon MC, Demers C, Jobin F, Wu JW. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999; 94: 3951-3953.
-
(1999)
Blood
, vol.94
, pp. 3951-3953
-
-
Poon, M.C.1
Demers, C.2
Jobin, F.3
Wu, J.W.4
-
14
-
-
0034041468
-
Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group
-
Poon MC, D'Oiron R. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group. Blood Coagul Fibrinolysis 2000; 11 (Suppl. 1): S55-S68.
-
(2000)
Blood Coagul Fibrinolysis
, vol.11
, Issue.SUPPL. 1
-
-
Poon, M.C.1
D'Oiron, R.2
-
15
-
-
0035198814
-
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia
-
Poon MC, D'Oiron R, Hann I et al. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol 2001; 33: 21-25.
-
(2001)
Semin Hematol
, vol.33
, pp. 21-25
-
-
Poon, M.C.1
D'Oiron, R.2
Hann, I.3
-
16
-
-
19944431107
-
Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey
-
Poon MC, D'Oiron R, Von Depka M, et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey. J Thromb Haemost 2004; 2: 1096-1103.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1096-1103
-
-
Poon, M.C.1
D'Oiron, R.2
Von Depka, M.3
-
17
-
-
0042427773
-
Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia
-
Caglar K, Cetinkaya A, Aytac S, Gumruk F, Gurgey A. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Pediatr Hematol Oncol 2003; 20: 435-438.
-
(2003)
Pediatr Hematol Oncol
, vol.20
, pp. 435-438
-
-
Caglar, K.1
Cetinkaya, A.2
Aytac, S.3
Gumruk, F.4
Gurgey, A.5
-
18
-
-
0141673285
-
Confirmation of high dose recombinant factor VIIa in treating patients with Glanzmann thrombasthenia
-
Chuansumrit A. Confirmation of high dose recombinant factor VIIa in treating patients with Glanzmann thrombasthenia. J Thromb Haemost 2003; 1: 396.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 396
-
-
Chuansumrit, A.1
-
19
-
-
0037298416
-
Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia
-
Chuansumrit A, Suwannuraks M, Sri-Udomporn N, Pongtanakul B, Worapongpaiboon S. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia. Blood Coagul Fibrinolysis 2003; 14: 187-190.
-
(2003)
Blood Coagul Fibrinolysis
, vol.14
, pp. 187-190
-
-
Chuansumrit, A.1
Suwannuraks, M.2
Sri-Udomporn, N.3
Pongtanakul, B.4
Worapongpaiboon, S.5
-
20
-
-
0038015845
-
The use of recombinant factor VIIa in children with inherited platelet function disorders
-
Almeida A, Khair K, Hann I, Liesner R. The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 2003; 121: 477-481.
-
(2003)
Br J Haematol
, vol.121
, pp. 477-481
-
-
Almeida, A.1
Khair, K.2
Hann, I.3
Liesner, R.4
-
21
-
-
0034062832
-
Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thromboasthenia undergoing invasive procedures
-
D'Oiron R, Menart C, Trzeciak MC et al. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thromboasthenia undergoing invasive procedures. Thromb Haemost 2000; 83: 644-647.
-
(2000)
Thromb Haemost
, vol.83
, pp. 644-647
-
-
D'Oiron, R.1
Menart, C.2
Trzeciak, M.C.3
-
22
-
-
33749565827
-
Use of rFVIIa in 4 children with Glanzmann Thromboasthenia
-
Valentino LA. Use of rFVIIa in 4 children with Glanzmann Thromboasthenia. J Pediatr Hematol Oncol 2004: 28: 653-658.
-
(2004)
J Pediatr Hematol Oncol
, vol.28
, pp. 653-658
-
-
Valentino, L.A.1
-
23
-
-
0031826843
-
Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa
-
Peters M, Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost 1998; 80: 352.
-
(1998)
Thromb Haemost
, vol.80
, pp. 352
-
-
Peters, M.1
Heijboer, H.2
-
24
-
-
0001030560
-
Use of recombinant factor VIIa (NovoSeven®) for dental extraction in a patient affected by platelet-type (pseudo-) von Willebrand disease
-
Fressinaud E, Sigaud-Fiks M, Le Boterff C, Piot B. Use of recombinant factor VIIa (NovoSeven®) for dental extraction in a patient affected by platelet-type (pseudo-) von Willebrand disease. Haemophilia 1998; 4: 299.
-
(1998)
Haemophilia
, vol.4
, pp. 299
-
-
Fressinaud, E.1
Sigaud-Fiks, M.2
Le Boterff, C.3
Piot, B.4
-
25
-
-
0141887093
-
Management of thrombocytopenic bleeding: Is there a role for recombinant coagulation factor VIIa?
-
Poon MC. Management of thrombocytopenic bleeding: Is there a role for recombinant coagulation factor VIIa? Curr Hematol Rep 2003; 2: 139-147.
-
(2003)
Curr Hematol Rep
, vol.2
, pp. 139-147
-
-
Poon, M.C.1
-
26
-
-
0842299575
-
Experiences with recombinant human factor VIIa in patients with thrombocytopenia
-
Goodnough LT. Experiences with recombinant human factor VIIa in patients with thrombocytopenia. Semin Hematol 2004; 41 (Suppl. 1): S25-S29.
-
(2004)
Semin Hematol
, vol.41
, Issue.SUPPL. 1
-
-
Goodnough, L.T.1
-
27
-
-
0037337665
-
Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura
-
Culic S. Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura. Br J Haematol 2003; 120: 909-910.
-
(2003)
Br J Haematol
, vol.120
, pp. 909-910
-
-
Culic, S.1
-
28
-
-
33748490487
-
Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia
-
Wrobel G, Dobaczewski G, Patkowski D, Sokol A, Grotthus E. Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia. Pediatr Blood Cancer 2006; 47: 729-730.
-
(2006)
Pediatr Blood Cancer
, vol.47
, pp. 729-730
-
-
Wrobel, G.1
Dobaczewski, G.2
Patkowski, D.3
Sokol, A.4
Grotthus, E.5
-
29
-
-
9044221759
-
Clinical experience with recombinant factor VIIa in patients with thrombocytopenia
-
Kristensen J, Killander A, Hippe E et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26 (Suppl. 1): S159-S164.
-
(1996)
Haemostasis
, vol.26
, Issue.SUPPL. 1
-
-
Kristensen, J.1
Killander, A.2
Hippe, E.3
-
30
-
-
0034824009
-
Off-label use of recombinant factor VIIa in patients following bone marrow transplantation
-
Blatt J, Gold SH, Wiley JM, Monahan PE, Cooper HC, Harvey D. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Bone Marrow Transplant 2001; 28: 405-407.
-
(2001)
Bone Marrow Transplant
, vol.28
, pp. 405-407
-
-
Blatt, J.1
Gold, S.H.2
Wiley, J.M.3
Monahan, P.E.4
Cooper, H.C.5
Harvey, D.6
-
31
-
-
2942611385
-
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies
-
de Fabritiis P, Dentamaro T, Picardi A, Cudillo R, Maci M, Amadori S. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies. Haematologica 2004; 89: 243-245.
-
(2004)
Haematologica
, vol.89
, pp. 243-245
-
-
de Fabritiis, P.1
Dentamaro, T.2
Picardi, A.3
Cudillo, R.4
Maci, M.5
Amadori, S.6
-
32
-
-
0036957457
-
Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa
-
Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant 2002; 30: 975-978.
-
(2002)
Bone Marrow Transplant
, vol.30
, pp. 975-978
-
-
Hicks, K.1
Peng, D.2
Gajewski, J.L.3
-
33
-
-
0034072273
-
Recombinant factor VIIa for bleeding in refractory thrombocytopenia
-
Vidarsson B, Onundarson PT. Recombinant factor VIIa for bleeding in refractory thrombocytopenia. Thromb Haemost 2000; 83: 634-635.
-
(2000)
Thromb Haemost
, vol.83
, pp. 634-635
-
-
Vidarsson, B.1
Onundarson, P.T.2
-
34
-
-
0036177902
-
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage
-
Gerotziafas GT, Zervas C, Gavrielidis G et al. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Am J Hematol 2002; 69: 219-222
-
(2002)
Am J Hematol
, vol.69
, pp. 219-222
-
-
Gerotziafas, G.T.1
Zervas, C.2
Gavrielidis, G.3
-
35
-
-
27544461945
-
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: An audit of the clinical use of recombinant activated factor VII
-
Brenner B, Hoffman R, Balashov D, Shutluko E, Culic SD, Nizamoutdinova E. Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: An audit of the clinical use of recombinant activated factor VII. Clin Appl Thromb Hemost 2005; 11: 401-410.
-
(2005)
Clin Appl Thromb Hemost
, vol.11
, pp. 401-410
-
-
Brenner, B.1
Hoffman, R.2
Balashov, D.3
Shutluko, E.4
Culic, S.D.5
Nizamoutdinova, E.6
-
36
-
-
33846034540
-
Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding
-
Mantzios G, Tsirigotis P, Pappa V et al. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding. Eur J Haematol 2007; 78: 173-174.
-
(2007)
Eur J Haematol
, vol.78
, pp. 173-174
-
-
Mantzios, G.1
Tsirigotis, P.2
Pappa, V.3
-
37
-
-
33644515311
-
Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization
-
Savani BN, Dunbar CE, Rick ME. Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization. Am J Hematol 2006; 81: 218-219.
-
(2006)
Am J Hematol
, vol.81
, pp. 218-219
-
-
Savani, B.N.1
Dunbar, C.E.2
Rick, M.E.3
-
38
-
-
0031851818
-
Recombinant factor VIIa in severe uremic bleeding
-
Revesz T, Arets B, Bierings M, van den Bos C, Duval E. Recombinant factor VIIa in severe uremic bleeding. Thromb Haemost 1998; 80: 353.
-
(1998)
Thromb Haemost
, vol.80
, pp. 353
-
-
Revesz, T.1
Arets, B.2
Bierings, M.3
van den Bos, C.4
Duval, E.5
-
39
-
-
0033825540
-
Recombinant factor VIIa treatment of bleeding associated with acute renal failure
-
Moisescu E, Ardelean L, Simion I, Muresan A, Ciupan R. Recombinant factor VIIa treatment of bleeding associated with acute renal failure. Blood Coagul Fibrinolysis 2000; 11: 575-577.
-
(2000)
Blood Coagul Fibrinolysis
, vol.11
, pp. 575-577
-
-
Moisescu, E.1
Ardelean, L.2
Simion, I.3
Muresan, A.4
Ciupan, R.5
-
40
-
-
0036169161
-
Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban
-
Stepinska J, Banaszewski M, Konopka A, Szajewski T. Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban. Thromb Haemost 2002; 87: 355-356.
-
(2002)
Thromb Haemost
, vol.87
, pp. 355-356
-
-
Stepinska, J.1
Banaszewski, M.2
Konopka, A.3
Szajewski, T.4
|